Patents by Inventor Milton H. Werner

Milton H. Werner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11725005
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: June 24, 2022
    Date of Patent: August 15, 2023
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20230159514
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: June 24, 2022
    Publication date: May 25, 2023
    Inventors: Milton H. Werner, Terence A. Kelly
  • Patent number: 11407747
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: January 5, 2021
    Date of Patent: August 9, 2022
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20210130343
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: January 5, 2021
    Publication date: May 6, 2021
    Inventors: Milton H. Werner, Terence A. Kelly
  • Patent number: 10906896
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: June 26, 2019
    Date of Patent: February 2, 2021
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20200046699
    Abstract: The present invention provides methods for the prevention or treatment of Parkinson's Disease using Abelson-family tyrosine kinase inhibitors.
    Type: Application
    Filed: October 25, 2017
    Publication date: February 13, 2020
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20200031819
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: June 26, 2019
    Publication date: January 30, 2020
    Inventors: Milton H. Werner, Terence A. Kelly
  • Patent number: 10344027
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: July 9, 2019
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Patent number: 10316031
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: June 11, 2019
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20190119266
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: October 24, 2018
    Publication date: April 25, 2019
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20190055234
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: October 24, 2018
    Publication date: February 21, 2019
    Inventors: Milton H. WERNER, Terence A. Kelly
  • Patent number: 10118923
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: November 6, 2018
    Assignee: Inhibikase Therapeutics, Inc.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20180057488
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: November 7, 2017
    Publication date: March 1, 2018
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20180022793
    Abstract: The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes.
    Type: Application
    Filed: April 6, 2017
    Publication date: January 25, 2018
    Inventors: Hyun Kang, Scott Sacane, Jonathan L. Moon, Erica B. Goodhew, Lopa Bhatt, Stacey L. Rose, Milton H. Werner
  • Patent number: 9828370
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: November 28, 2017
    Assignee: INHIBIKASE THERAPEUTICS, INC.
    Inventors: Milton H. Werner, Terence A. Kelly
  • Patent number: 9617330
    Abstract: The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes.
    Type: Grant
    Filed: February 2, 2010
    Date of Patent: April 11, 2017
    Assignee: Celtaxsys, Inc.
    Inventors: Hyun Kang, Scott Sacane, Jonathan L. Moon, Erica B. Goodhew, Lopa Bhatt, Stacey L. Rose, Milton H. Werner
  • Patent number: 9487500
    Abstract: Novel compounds and their synthesis are described. Methods for using these compounds in the prevention or treatment of cancer, a bacterial infection or a viral infection in a subject are also described.
    Type: Grant
    Filed: October 4, 2013
    Date of Patent: November 8, 2016
    Assignee: INHIBIKASE THERAPEUTICS, INC.
    Inventors: Rhushikesh C. Deokar, Sundeep H. Dugar, Dinesh Mahajan, Milton H. Werner
  • Publication number: 20160311816
    Abstract: The present invention provides compounds for the prevention or treatment of cancer or a bacterial or viral infection. Additionally, the present invention provides compositions and methods for using these compounds and compositions in the prevention or treatment of cancer or a bacterial or viral infection in a subject.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 27, 2016
    Inventors: Milton H. Werner, Terence A. Kelly
  • Publication number: 20160101106
    Abstract: The present invention provides methods of treating HCV infection in subjects (e.g., mammals), comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor or a prodrug thereof. The present invention also provides methods of treating HCV infection, comprising administering to a subject in need thereof an effective amount of a RAF kinase inhibitor conjointly with at least one additional therapeutic agent (e.g., an antiviral agent).
    Type: Application
    Filed: May 6, 2014
    Publication date: April 14, 2016
    Applicant: Inhibikase Therapeutics, Inc.
    Inventor: Milton H Werner
  • Publication number: 20100203087
    Abstract: The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel chemorepellents and unimodal fugetaxins, their agonists and antagonists which alter or affect the movement of cells involved in immune, inflammatory or cancerous phenotypes.
    Type: Application
    Filed: February 2, 2010
    Publication date: August 12, 2010
    Inventors: Hyun Kang, Scott Sacane, Jonathan L. Moon, Erica B. Goodhew, Lopa Bhatt, Stacey L. Rose, Milton H. Werner